We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
(-43%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-89.66%
Top 10 Holdings %
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1
quarters
Top 10 Avg Time Held Equity + Options
0.1
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
4.3
quarters
Top 10 Avg Time Held Equity only
0.1
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pioneer Natural Resource Co.
PXD
|
+$604M |
| 2 |
Splunk Inc
SPLK
|
+$446M |
| 3 |
Hess
HES
|
+$339M |
| 4 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$106M |
| 5 |
US Steel
X
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.06B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$887M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$371M |
| 4 |
VMW
VMware, Inc
VMW
|
+$354M |
| 5 |
NEWR
New Relic, Inc.
NEWR
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 29.51% |
| 2 | Technology | 21.97% |
| 3 | Healthcare | 10.49% |
| 4 | Miscellaneous | 10.26% |
| 5 | Real Estate | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $22.1K | ﹤0.01% |
+55,000
| New | +$451K |
2023 Q4
0 quarters
|
|
427
CALL
Legend Biotech
LEGN
$3.52B
| $21.6K | ﹤0.01% |
+12,500
| New | +$792K |
2023 Q4
0 quarters
|
|
428
CALL
AbbVie
ABBV
$490B
| $21.6K | ﹤0.01% |
+10,000
| New | +$1.46M |
2023 Q4
0 quarters
|
|
429
CALL
DELISTED
Ventyx Biosciences
VTYX
| $18.8K | ﹤0.01% |
50,000
+20,000
| +67% | +$190K |
2023 Q3
1 quarter
|
|
430
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $18.8K | ﹤0.01% |
50,000
-40,000
| -44% | -$712K |
2023 Q3
1 quarter
|
|
431
PUT
Macy's
M
$5.87B
| $17.1K | ﹤0.01% |
131,000
| – | – |
2021 Q2
10 quarters
|
|
432
PUT
Rhythm Pharmaceuticals
RYTM
$6.19B
| $16.9K | ﹤0.01% |
+25,000
| New | +$789K |
2023 Q4
0 quarters
|
|
433
PUT
Brookfield Infrastructure Partners
BIP
$17B
| $16.8K | ﹤0.01% |
+167,500
| New | +$4.53M |
2023 Q4
0 quarters
|
|
434
DELISTED
Cartesian Growth Corporation II Warrant
RENEW
| $16.6K | ﹤0.01% |
+122,826
| New | +$15.8K |
2023 Q4
0 quarters
|
|
|
BSLKW
435
DELISTED
Bolt Projects Holdings Warrant
BSLKW
| $16K | ﹤0.01% |
114,498
-51,465
| -31% | -$6.11K |
2022 Q1
7 quarters
|
|
436
CALL
CRISPR Therapeutics
CRSP
$5.09B
| $15K | ﹤0.01% |
+15,000
| New | +$829K |
2023 Q4
0 quarters
|
|
437
Kodiak AI Warrants
KDKRW
| $13.7K | ﹤0.01% |
+85,383
| New | +$16.5K |
2023 Q4
0 quarters
|
|
438
CALL
FuboTV Inc
FUBO
$268M
| $11.5K | ﹤0.01% |
8,333
| – | – |
2023 Q1
3 quarters
|
|
439
DELISTED
USA Rare Earth Inc Warrant
USARW
| $10.9K | ﹤0.01% |
+103,486
| New | +$14.9K |
2023 Q4
0 quarters
|
|
|
DISH
440
CALL
DELISTED
DISH Network Corp.
DISH
| $10.5K | ﹤0.01% |
100,000
| – | – |
2023 Q1
3 quarters
|
|
441
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
| $9.84K | ﹤0.01% |
+78,716
| New | +$10.2K |
2023 Q4
0 quarters
|
|
442
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
| $9.82K | ﹤0.01% |
126,755
-57,331
| -31% | -$3.82K |
2021 Q2
10 quarters
|
|
443
PUT
Intuitive Surgical
ISRG
$149B
| $9.07K | ﹤0.01% |
+11,000
| New | +$3.28M |
2023 Q4
0 quarters
|
|
444
DELISTED
Jet.AI Inc. Warrant
JTAIW
| $8.94K | ﹤0.01% |
197,427
| – | – |
2022 Q3
5 quarters
|
|
445
DELISTED
SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SBXC.WS
| $8.43K | ﹤0.01% |
+91,076
| New | +$11.1K |
2023 Q4
0 quarters
|
|
446
PUT
Delta Air Lines
DAL
$53.5B
| $8.27K | ﹤0.01% |
27,900
| – | – |
2021 Q2
10 quarters
|
|
447
CALL
Karyopharm Therapeutics
KPTI
$13M
| $7.5K | ﹤0.01% |
20,000
| – | – |
2023 Q3
1 quarter
|
|
448
MultiSensor AI Holdings Warrant
MSAIW
$715K
| $7.34K | ﹤0.01% |
+145,732
| New | +$5.71K |
2023 Q4
0 quarters
|
|
449
DELISTED
SEP Acquisition Corp Warrants
SEPAW
| $7.08K | ﹤0.01% |
80,900
-36,363
| -31% | -$3.77K |
2022 Q4
4 quarters
|
|
450
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
| $6.97K | ﹤0.01% |
+214,435
| New | +$10.4K |
2023 Q4
0 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2023 Portfolio in Review
As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.
By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.
- UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
- UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
- UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
- UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
- UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
- UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.
Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.